Dr. Paul M. Hendrix, M.D.
Gastroenterology (Gastroenterology Physician)
2770 Cortez Ave
Idaho Falls, ID 83404
Who else practices at this address →
Bonneville County includes primary care (1% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Louisiana State University School of Medicine in New Orleans (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 361
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Louisiana State University School of Medicine in New Orleans
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
ID license M6489
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mountain View Hospital Idaho Falls, ID
- Idaho Falls Community Hospital, LLC Idaho Falls, ID
Medical groups
- Mountain View Hospital LLC (276 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 361
- Services billed
- 683
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 113 | 110 |
| Established patient office or other outpatient visit, 30-39 minutes | 91 | 79 |
| Biopsy of large bowel using a flexible endoscope | 75 | 74 |
| New patient office or other outpatient visit, 45-59 minutes | 65 | 65 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 52 | 51 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 39 | 39 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 31 | 31 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 24 | 24 |
| Diagnostic exam of large bowel using a flexible endoscope | 19 | 19 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 18 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Omeprazole Other prescribers in Idaho Falls, ID | 350 |
| Sod Sulf-Potass Sulf-Mag Sulf (sodium, potassium,mag sulfates) Other prescribers in Idaho Falls, ID | 154 |
| Pantoprazole Sodium Other prescribers in Idaho Falls, ID | 50 |
| Budesonide Dr (budesonide) Other prescribers in Idaho Falls, ID | 30 |
| Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Idaho Falls, ID | 23 |
| Dicyclomine Hcl Other prescribers in Idaho Falls, ID | 23 |
| Peg-3350 And Electrolytes (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Idaho Falls, ID | 21 |
| Pentasa (mesalamine) Other prescribers in Idaho Falls, ID | 21 |
| Sucralfate Other prescribers in Idaho Falls, ID | 20 |
| Colestipol Hcl Other prescribers in Idaho Falls, ID | 19 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 5 payments worth $94.80 in total to this clinician.
| AbbVie Inc. | $57.15 |
|---|---|
| Boston Scientific Corporation | $22.41 |
| Genzyme Corporation | $15.24 |
| Food and Beverage | $94.80 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $38,551 in research payments for these studies, mostly to the institutions running them.
- An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Celgene Corporation · Terminated · NCT03467958 - Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Celgene Corporation · Completed · NCT03440385 - A Phase 3, Multicenter, Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
E.r. Squibb & Sons, L.l.c.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.